Evidence check: APOE in the context of menopause

The provided context does not contain specific evidence on APOE in the context of menopause. APOE (especially the ε4 allele) is a well-established risk factor for late-onset Alzheimer's disease and cardiovascular disease. During menopause, estrogen decline may interact with APOE4 to increase risks for cognitive decline and adverse lipid profiles. However, the evidence for this interaction is moderate, mostly from observational studies, and does not support direct clinical recommendations. Consumer genetic tests often overstate the implications. A comprehensive risk assessment should consider lifestyle and other factors. Without context-specific evidence, the evidence grade remains unclear.